ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Therapeutic Protein Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-26W13504
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Therapeutic Protein Market Research Report 2023
BUY CHAPTERS

Global Recombinant Therapeutic Protein Market Research Report 2025

Code: QYRE-Auto-26W13504
Report
January 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boehringer Ingelheim
Bristol–Myers Squibb
Celldex Therapeutics
Eli Liily
GlaxoSmithKline PLC
Merck
Novartis
Regeneron Pharmaceuticals
Roche
Takeda

Recombinant Therapeutic Protein Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Recombinant Therapeutic Protein Market

Recombinant Therapeutic Protein Market

The global market for Recombinant Therapeutic Protein was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Recombinant Therapeutic Protein are produced by using a technique called recombinant DNA or recombinant RNA to produce proteins. The method can be divided into in vitro method and in vivo method. Both approaches are premised on the use of genetic recombination techniques to obtain recombinant vectors attached to gene fragments that can be translated into target proteins and then transferred to host cells that can express target proteins to express specific recombinant governance protein molecules.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Therapeutic Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Therapeutic Protein.
The Recombinant Therapeutic Protein market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Therapeutic Protein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Therapeutic Protein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Therapeutic Protein Market Report

Report Metric Details
Report Name Recombinant Therapeutic Protein Market
CAGR 5%
Segment by Type
Segment by Application
  • Medicine
  • Scientific Research
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Bristol-Myers Squibb, Celldex Therapeutics, Eli Liily, GlaxoSmithKline, Merck, Novartis, Regeneron Pharmaceuticals, Roche, Takeda
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Therapeutic Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Therapeutic Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Recombinant Therapeutic Protein Market report?

Ans: The main players in the Recombinant Therapeutic Protein Market are Boehringer Ingelheim, Bristol-Myers Squibb, Celldex Therapeutics, Eli Liily, GlaxoSmithKline, Merck, Novartis, Regeneron Pharmaceuticals, Roche, Takeda

What are the Application segmentation covered in the Recombinant Therapeutic Protein Market report?

Ans: The Applications covered in the Recombinant Therapeutic Protein Market report are Medicine, Scientific Research, Others

What are the Type segmentation covered in the Recombinant Therapeutic Protein Market report?

Ans: The Types covered in the Recombinant Therapeutic Protein Market report are Recombinant Human Collage, Recombinant Human Serum Albumin

Recommended Reports

Recombinant Proteins

Gene & Cell Therapy

Therapeutic Drugs

1 Recombinant Therapeutic Protein Market Overview
1.1 Product Definition
1.2 Recombinant Therapeutic Protein by Type
1.2.1 Global Recombinant Therapeutic Protein Market Value Comparison by Type (2024 VS 2031)
1.2.2 Recombinant Human Collage
1.2.3 Recombinant Human Serum Albumin
1.3 Recombinant Therapeutic Protein by Application
1.3.1 Global Recombinant Therapeutic Protein Market Value by Application (2024 VS 2031)
1.3.2 Medicine
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Recombinant Therapeutic Protein Market Size Estimates and Forecasts
1.4.1 Global Recombinant Therapeutic Protein Revenue 2020-2031
1.4.2 Global Recombinant Therapeutic Protein Sales 2020-2031
1.4.3 Global Recombinant Therapeutic Protein Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Therapeutic Protein Market Competition by Manufacturers
2.1 Global Recombinant Therapeutic Protein Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Therapeutic Protein Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Therapeutic Protein Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Therapeutic Protein, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Therapeutic Protein, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Therapeutic Protein, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Therapeutic Protein, Date of Enter into This Industry
2.8 Global Recombinant Therapeutic Protein Market Competitive Situation and Trends
2.8.1 Global Recombinant Therapeutic Protein Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Therapeutic Protein Players Market Share by Revenue
2.8.3 Global Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Therapeutic Protein Market Scenario by Region
3.1 Global Recombinant Therapeutic Protein Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Therapeutic Protein Sales by Region: 2020-2031
3.2.1 Global Recombinant Therapeutic Protein Sales by Region: 2020-2025
3.2.2 Global Recombinant Therapeutic Protein Sales by Region: 2026-2031
3.3 Global Recombinant Therapeutic Protein Revenue by Region: 2020-2031
3.3.1 Global Recombinant Therapeutic Protein Revenue by Region: 2020-2025
3.3.2 Global Recombinant Therapeutic Protein Revenue by Region: 2026-2031
3.4 North America Recombinant Therapeutic Protein Market Facts & Figures by Country
3.4.1 North America Recombinant Therapeutic Protein Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Therapeutic Protein Sales by Country (2020-2031)
3.4.3 North America Recombinant Therapeutic Protein Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Recombinant Therapeutic Protein Market Facts & Figures by Country
3.5.1 Europe Recombinant Therapeutic Protein Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Therapeutic Protein Sales by Country (2020-2031)
3.5.3 Europe Recombinant Therapeutic Protein Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Therapeutic Protein Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Therapeutic Protein Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Therapeutic Protein Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Therapeutic Protein Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Recombinant Therapeutic Protein Market Facts & Figures by Country
3.7.1 Latin America Recombinant Therapeutic Protein Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Therapeutic Protein Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Therapeutic Protein Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Therapeutic Protein Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Therapeutic Protein Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Therapeutic Protein Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Recombinant Therapeutic Protein Sales by Type (2020-2031)
4.1.1 Global Recombinant Therapeutic Protein Sales by Type (2020-2025)
4.1.2 Global Recombinant Therapeutic Protein Sales by Type (2026-2031)
4.1.3 Global Recombinant Therapeutic Protein Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Therapeutic Protein Revenue by Type (2020-2031)
4.2.1 Global Recombinant Therapeutic Protein Revenue by Type (2020-2025)
4.2.2 Global Recombinant Therapeutic Protein Revenue by Type (2026-2031)
4.2.3 Global Recombinant Therapeutic Protein Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Therapeutic Protein Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Therapeutic Protein Sales by Application (2020-2031)
5.1.1 Global Recombinant Therapeutic Protein Sales by Application (2020-2025)
5.1.2 Global Recombinant Therapeutic Protein Sales by Application (2026-2031)
5.1.3 Global Recombinant Therapeutic Protein Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Therapeutic Protein Revenue by Application (2020-2031)
5.2.1 Global Recombinant Therapeutic Protein Revenue by Application (2020-2025)
5.2.2 Global Recombinant Therapeutic Protein Revenue by Application (2026-2031)
5.2.3 Global Recombinant Therapeutic Protein Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Therapeutic Protein Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Company Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer Ingelheim Recombinant Therapeutic Protein Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Bristol-Myers Squibb
6.2.1 Bristol-Myers Squibb Company Information
6.2.2 Bristol-Myers Squibb Description and Business Overview
6.2.3 Bristol-Myers Squibb Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bristol-Myers Squibb Recombinant Therapeutic Protein Product Portfolio
6.2.5 Bristol-Myers Squibb Recent Developments/Updates
6.3 Celldex Therapeutics
6.3.1 Celldex Therapeutics Company Information
6.3.2 Celldex Therapeutics Description and Business Overview
6.3.3 Celldex Therapeutics Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Celldex Therapeutics Recombinant Therapeutic Protein Product Portfolio
6.3.5 Celldex Therapeutics Recent Developments/Updates
6.4 Eli Liily
6.4.1 Eli Liily Company Information
6.4.2 Eli Liily Description and Business Overview
6.4.3 Eli Liily Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Eli Liily Recombinant Therapeutic Protein Product Portfolio
6.4.5 Eli Liily Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Company Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)
6.5.4 GlaxoSmithKline Recombinant Therapeutic Protein Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 Merck
6.6.1 Merck Company Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Merck Recombinant Therapeutic Protein Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Novartis
6.7.1 Novartis Company Information
6.7.2 Novartis Description and Business Overview
6.7.3 Novartis Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Novartis Recombinant Therapeutic Protein Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Regeneron Pharmaceuticals
6.8.1 Regeneron Pharmaceuticals Company Information
6.8.2 Regeneron Pharmaceuticals Description and Business Overview
6.8.3 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product Portfolio
6.8.5 Regeneron Pharmaceuticals Recent Developments/Updates
6.9 Roche
6.9.1 Roche Company Information
6.9.2 Roche Description and Business Overview
6.9.3 Roche Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Roche Recombinant Therapeutic Protein Product Portfolio
6.9.5 Roche Recent Developments/Updates
6.10 Takeda
6.10.1 Takeda Company Information
6.10.2 Takeda Description and Business Overview
6.10.3 Takeda Recombinant Therapeutic Protein Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Takeda Recombinant Therapeutic Protein Product Portfolio
6.10.5 Takeda Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Therapeutic Protein Industry Chain Analysis
7.2 Recombinant Therapeutic Protein Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Therapeutic Protein Production Mode & Process Analysis
7.4 Recombinant Therapeutic Protein Sales and Marketing
7.4.1 Recombinant Therapeutic Protein Sales Channels
7.4.2 Recombinant Therapeutic Protein Distributors
7.5 Recombinant Therapeutic Protein Customer Analysis
8 Recombinant Therapeutic Protein Market Dynamics
8.1 Recombinant Therapeutic Protein Industry Trends
8.2 Recombinant Therapeutic Protein Market Drivers
8.3 Recombinant Therapeutic Protein Market Challenges
8.4 Recombinant Therapeutic Protein Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Boehringer Ingelheim
Bristol–Myers Squibb
Celldex Therapeutics
Eli Liily
GlaxoSmithKline PLC
Merck
Novartis
Regeneron Pharmaceuticals
Roche
Takeda
List of Tables
 Table 1. Global Recombinant Therapeutic Protein Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Therapeutic Protein Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Therapeutic Protein Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Therapeutic Protein Sales (MT) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Therapeutic Protein Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Therapeutic Protein Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Therapeutic Protein Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Therapeutic Protein Average Price (USD/MT) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Therapeutic Protein, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Therapeutic Protein, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Therapeutic Protein, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Therapeutic Protein, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Therapeutic Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Therapeutic Protein as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Therapeutic Protein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Therapeutic Protein Sales by Region (2020-2025) & (MT)
 Table 18. Global Recombinant Therapeutic Protein Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Therapeutic Protein Sales by Region (2026-2031) & (MT)
 Table 20. Global Recombinant Therapeutic Protein Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Therapeutic Protein Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Therapeutic Protein Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Therapeutic Protein Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Therapeutic Protein Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Therapeutic Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Therapeutic Protein Sales by Country (2020-2025) & (MT)
 Table 27. North America Recombinant Therapeutic Protein Sales by Country (2026-2031) & (MT)
 Table 28. North America Recombinant Therapeutic Protein Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Therapeutic Protein Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Therapeutic Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Therapeutic Protein Sales by Country (2020-2025) & (MT)
 Table 32. Europe Recombinant Therapeutic Protein Sales by Country (2026-2031) & (MT)
 Table 33. Europe Recombinant Therapeutic Protein Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Therapeutic Protein Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Therapeutic Protein Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Therapeutic Protein Sales by Region (2020-2025) & (MT)
 Table 37. Asia Pacific Recombinant Therapeutic Protein Sales by Region (2026-2031) & (MT)
 Table 38. Asia Pacific Recombinant Therapeutic Protein Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Therapeutic Protein Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Therapeutic Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Therapeutic Protein Sales by Country (2020-2025) & (MT)
 Table 42. Latin America Recombinant Therapeutic Protein Sales by Country (2026-2031) & (MT)
 Table 43. Latin America Recombinant Therapeutic Protein Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Therapeutic Protein Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Therapeutic Protein Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2020-2025) & (MT)
 Table 47. Middle East and Africa Recombinant Therapeutic Protein Sales by Country (2026-2031) & (MT)
 Table 48. Middle East and Africa Recombinant Therapeutic Protein Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Therapeutic Protein Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Therapeutic Protein Sales (MT) by Type (2020-2025)
 Table 51. Global Recombinant Therapeutic Protein Sales (MT) by Type (2026-2031)
 Table 52. Global Recombinant Therapeutic Protein Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Therapeutic Protein Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Therapeutic Protein Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Therapeutic Protein Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Therapeutic Protein Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Therapeutic Protein Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Therapeutic Protein Price (USD/MT) by Type (2020-2025)
 Table 59. Global Recombinant Therapeutic Protein Price (USD/MT) by Type (2026-2031)
 Table 60. Global Recombinant Therapeutic Protein Sales (MT) by Application (2020-2025)
 Table 61. Global Recombinant Therapeutic Protein Sales (MT) by Application (2026-2031)
 Table 62. Global Recombinant Therapeutic Protein Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Therapeutic Protein Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Therapeutic Protein Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Therapeutic Protein Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Therapeutic Protein Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Therapeutic Protein Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Therapeutic Protein Price (USD/MT) by Application (2020-2025)
 Table 69. Global Recombinant Therapeutic Protein Price (USD/MT) by Application (2026-2031)
 Table 70. Boehringer Ingelheim Company Information
 Table 71. Boehringer Ingelheim Description and Business Overview
 Table 72. Boehringer Ingelheim Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 73. Boehringer Ingelheim Recombinant Therapeutic Protein Product
 Table 74. Boehringer Ingelheim Recent Developments/Updates
 Table 75. Bristol-Myers Squibb Company Information
 Table 76. Bristol-Myers Squibb Description and Business Overview
 Table 77. Bristol-Myers Squibb Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 78. Bristol-Myers Squibb Recombinant Therapeutic Protein Product
 Table 79. Bristol-Myers Squibb Recent Developments/Updates
 Table 80. Celldex Therapeutics Company Information
 Table 81. Celldex Therapeutics Description and Business Overview
 Table 82. Celldex Therapeutics Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 83. Celldex Therapeutics Recombinant Therapeutic Protein Product
 Table 84. Celldex Therapeutics Recent Developments/Updates
 Table 85. Eli Liily Company Information
 Table 86. Eli Liily Description and Business Overview
 Table 87. Eli Liily Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 88. Eli Liily Recombinant Therapeutic Protein Product
 Table 89. Eli Liily Recent Developments/Updates
 Table 90. GlaxoSmithKline Company Information
 Table 91. GlaxoSmithKline Description and Business Overview
 Table 92. GlaxoSmithKline Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 93. GlaxoSmithKline Recombinant Therapeutic Protein Product
 Table 94. GlaxoSmithKline Recent Developments/Updates
 Table 95. Merck Company Information
 Table 96. Merck Description and Business Overview
 Table 97. Merck Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 98. Merck Recombinant Therapeutic Protein Product
 Table 99. Merck Recent Developments/Updates
 Table 100. Novartis Company Information
 Table 101. Novartis Description and Business Overview
 Table 102. Novartis Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 103. Novartis Recombinant Therapeutic Protein Product
 Table 104. Novartis Recent Developments/Updates
 Table 105. Regeneron Pharmaceuticals Company Information
 Table 106. Regeneron Pharmaceuticals Description and Business Overview
 Table 107. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 108. Regeneron Pharmaceuticals Recombinant Therapeutic Protein Product
 Table 109. Regeneron Pharmaceuticals Recent Developments/Updates
 Table 110. Roche Company Information
 Table 111. Roche Description and Business Overview
 Table 112. Roche Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 113. Roche Recombinant Therapeutic Protein Product
 Table 114. Roche Recent Developments/Updates
 Table 115. Takeda Company Information
 Table 116. Takeda Description and Business Overview
 Table 117. Takeda Recombinant Therapeutic Protein Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 118. Takeda Recombinant Therapeutic Protein Product
 Table 119. Takeda Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Recombinant Therapeutic Protein Distributors List
 Table 123. Recombinant Therapeutic Protein Customers List
 Table 124. Recombinant Therapeutic Protein Market Trends
 Table 125. Recombinant Therapeutic Protein Market Drivers
 Table 126. Recombinant Therapeutic Protein Market Challenges
 Table 127. Recombinant Therapeutic Protein Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Therapeutic Protein
 Figure 2. Global Recombinant Therapeutic Protein Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Therapeutic Protein Market Share by Type: 2024 & 2031
 Figure 4. Recombinant Human Collage Product Picture
 Figure 5. Recombinant Human Serum Albumin Product Picture
 Figure 6. Global Recombinant Therapeutic Protein Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Recombinant Therapeutic Protein Market Share by Application: 2024 & 2031
 Figure 8. Medicine
 Figure 9. Scientific Research
 Figure 10. Others
 Figure 11. Global Recombinant Therapeutic Protein Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Recombinant Therapeutic Protein Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Recombinant Therapeutic Protein Sales (2020-2031) & (MT)
 Figure 14. Global Recombinant Therapeutic Protein Average Price (USD/MT) & (2020-2031)
 Figure 15. Recombinant Therapeutic Protein Report Years Considered
 Figure 16. Recombinant Therapeutic Protein Sales Share by Manufacturers in 2024
 Figure 17. Global Recombinant Therapeutic Protein Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Recombinant Therapeutic Protein Players: Market Share by Revenue in Recombinant Therapeutic Protein in 2024
 Figure 19. Recombinant Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Recombinant Therapeutic Protein Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Recombinant Therapeutic Protein Sales Market Share by Country (2020-2031)
 Figure 22. North America Recombinant Therapeutic Protein Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Recombinant Therapeutic Protein Sales Market Share by Country (2020-2031)
 Figure 26. Europe Recombinant Therapeutic Protein Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Recombinant Therapeutic Protein Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Recombinant Therapeutic Protein Revenue Market Share by Region (2020-2031)
 Figure 34. China Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Recombinant Therapeutic Protein Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Recombinant Therapeutic Protein Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Recombinant Therapeutic Protein Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Recombinant Therapeutic Protein Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Recombinant Therapeutic Protein Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Recombinant Therapeutic Protein by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Recombinant Therapeutic Protein by Type (2020-2031)
 Figure 56. Global Recombinant Therapeutic Protein Price (USD/MT) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Recombinant Therapeutic Protein by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Recombinant Therapeutic Protein by Application (2020-2031)
 Figure 59. Global Recombinant Therapeutic Protein Price (USD/MT) by Application (2020-2031)
 Figure 60. Recombinant Therapeutic Protein Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Therapeutic Recombinant Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Recombinant Protein Therapeutics Market
Global Recombinant Proteins Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Recombinant Protein Expression System Market Research Report 2024
Recombinant Peptide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gene Recombinant Protein Market Research Report 2024
Global Recombinant Protein Vaccine Market Insights Forecast to 2030
Global Recombinant Protein Reagents Market Research Report 2025
Global Recombinant Protein Drug R D Market Research Report 2024
Global Recombinant Protein Peptide Drug Market Research Report 2024
Global Recombinant Plasma Protein Therapeutics Market Insights Forecast to 2030
Recombinant Protein Expression and Purification Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Protein Drug Market Research Report 2024
Recombinant Protein Drugs Market
Global Recombinant Protein Service Market Research Report 2025
Global Recombinant Plasma Proteins Market Insights Forecast to 2030
Global Recombinant Protein Industrial Reagents Market Research Report 2024
Global Prokaryotic Recombinant Protein Market Research Report 2024
Recombinant DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Therapeutic Proteins for Cardiovascular Disorders Treatment Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions